ReviewJournal of clinical medicine2023
Surgical Challenges in Infective Endocarditis: State of the Art.
Review in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 25 citations in OpenAlex.
- Burden of cardiovascular diseases in the Asia-Pacific region from 1990 to 2023, with forecasts to 2050: a secondary analysis of the Global Burden of disease study 2023.The Lancet regional health. Western Pacific · 2026Article
- Reconstruction of the Aorto-Mitral Curtain in Complex Infective Endocarditis: A Contemporary Narrative Review of the Commando Procedure.Reviews in cardiovascular medicine · 2026Review
- Vacuum-Assisted Percutaneous Management of Cardiac Implantable Electronic Device Lead Endocarditis.Journal of clinical medicine · 2026Review
- The "Commando" Procedure in Colombia: Early and Mid-Term Outcomes From the Largest Latin American Series.Interdisciplinary cardiovascular and thoracic surgery · 2026Article
- Infective Endocarditis and Complications; Surgical Indications and Management: An Integrative Review.Journal of personalized medicine · 2026Review
- Annular reconstruction in infective endocarditis: Comparative analysis of surgical outcomes and infection recurrence.Medicine · 2026Observational
- Mitral Valve Repair for the Treatment of Acute Bacterial Endocarditis: Analysis of a 10-Year Single-Center Experience.Journal of clinical medicine · 2025Article
- Long-term outcomes of surgical repair versus replacement for tricuspid valve endocarditis - AInternational journal of cardiology. Heart & vasculature · 2025Article
- Epidemiology, Pathogenesis, Clinical Features, and Management of Non-HACEK Gram-Negative Infective Endocarditis.Antibiotics (Basel, Switzerland) · 2025Review
- Review
- Transapical Mitral Valve Implantation After Closure of Posterior Mitral Annulus Cavity With a Nitinol Occluder.JACC. Case reports · 2025Article
- Trends in the Clinical Characteristics and Outcome of Infective Endocarditis: A Nationwide Study From 2016 to 2021.Journal of the American Heart Association · 2025Article
- Reintervention for Acute Aortic Prosthesis Endocarditis: Early and Mid-Term Outcomes.Journal of clinical medicine · 2024Article
- Breaking the Dogma of Intravenous Treatment for Infective Endocarditis: A Systematic Review and Meta-Analysis.Journal of clinical medicine · 2024Review
- Can Radiological Renal Artery Parameters Predict Acute Kidney Injury in Infective Endocarditis Surgery?-From Imaging to Outcomes.Diagnostics (Basel, Switzerland) · 2024Article
- Abiotrophia defectiva: A Rare Causative Agent of Infective Endocarditis With Severe Complications.Cureus · 2024Article
- Impact of Psoas Muscle Area Index on Short- and Mid-Term Mortality in Patients Undergoing Valve Surgery for Infective Endocarditis: A Retrospective Analysis.Diagnostics (Basel, Switzerland) · 2024Article
- From flank pain to splenic abscess: a complex case of infective endocarditis with literature review.BMC cardiovascular disorders · 2024Review
- Beyond the Valve: Incidence, Outcomes, and Modifiable Factors of Acute Kidney Injury in Patients with Infective Endocarditis Undergoing Valve Surgery-A Retrospective, Single-Center Study.Journal of clinical medicine · 2024Article
- Clinical Features and Patient Outcomes in Infective Endocarditis with Surgical Indication: A Single-Centre Experience.Journal of cardiovascular development and disease · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infective endocarditis (IE) is still a life-threatening disease with frequent lethal outcomes despite the profound changes in its clinical, microbiological, imaging, and therapeutic profiles. Nowadays, the scenario for IE has changed since rheumatic fever has declined, but on the other hand, multiple aspects, such as elderly populations, cardiovascular device implantation procedures, and better use of multiple imaging modalities and multidisciplinary care, have increased, leading to escalations in diagnosis. Since the ESC and AHA Guidelines have been released, specific aspects of diagnostic and therapeutic management have been clarified to provide better and faster diagnosis and prognosis. Surgical treatment is required in approximately half of patients with IE in order to avoid progressive heart failure, irreversible structural damage in the case of uncontrolled infection, and the prevention of embolism. The timing of surgery has been one of the main aspects discussed, identifying cases in which surgery needs to be performed on an emergency (within 24 h) or urgent (within 7 days) basis, irrespective of the duration of antibiotic treatment, or cases where surgery can be postponed to allow a brief period of antibiotic treatment under careful clinical and echocardiographic observation. Mainly, guidelines put emphasis on the importance of an endocarditis team in the handling of systemic complications and how they affect the timing of surgery and perioperative management. Neurological complications, acute renal failure, splenic or musculoskeletal manifestations, or infections determined by multiresistant microorganisms or fungi can affect long-term prognosis and survival. Not to be outdone, anatomical and surgical factors, such as the presence of native or prosthetic valve endocarditis, a repair strategy when feasible, anatomical extension and disruption in the case of an annular abscess (mitral valve annulus, aortic mitral curtain, aortic root, and annulus), and the choice of prosthesis and conduits, can be equally crucial. It can be hard for surgeons to maneuver between correct pre-operative planning and facing unexpected obstacles during intraoperative management. The aim of this review is to provide an overview and analysis of a broad spectrum of specific surgical scenarios and how their challenging management can be essential to ensure better outcomes and prognoses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.